BIFURCATION ANALYSIS IN A SEROGROUP A MENINGOCOCCAL INFECTION MODEL

被引:1
作者
Bah, Alpha Oumar [1 ]
Lam, Mountaga [1 ]
Bah, Alassane [2 ]
Bowong, Samuel [3 ]
机构
[1] Univ Cheikh Anta Diop, Dept Math, Fac Sci & Tech, Dakar, Senegal
[2] Univ Cheikh Anta Diop, Natl Adv Sch Engn, Dept Comp Engn, Dakar, Senegal
[3] Univ Douala, Fac Sci, Dept Math & Comp Sci, Lab Math, POB 24157, Douala, Cameroon
关键词
epidemiological models; serogroup A meningococcal infection; stability; bifurcation; NEISSERIA-MENINGITIDIS; BACKWARD BIFURCATION; SENSITIVITY-ANALYSIS; VACCINATION; DISEASE; EPIDEMIC; TUBERCULOSIS; W135; TRANSMISSION; UNCERTAINTY;
D O I
10.28919/cmbn/3760
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
A mathematical model is formulated that enables the understanding of the dynamics of the transmission of serogroup A meningococcal (MenA) infection. We provide the theoretical analysis of the model. We compute the basic reproduction number R-0 and shows that the outcome of the disease depends on a threshold parameter xi. More precisely, we show that when R-0 <= xi, the disease-free equilibrium is globally asymptotically stable, while when xi <= R-0 <= 1, the model exhibits the phenomenon of backward bifurcation, when a stable diseasefree equilibrium co-exists with one or more stable endemic equilibria. Sensitivity analysis of the model has been performed in order to determine the impact of related parameters on meningitis outbreak. Random perturbation of the vaccine efficacy was performed to gain insight into the role of the vaccine efficacy on the stability of the disease-free equilibrium. Theoretical results are supported by numerical simulations, which further suggest that the control of the epidemic of MenA pass through a combination of a large coverage vaccination of young susceptible individuals and the production of a vaccine with a high level of efficacy.
引用
收藏
页数:38
相关论文
共 50 条
  • [41] Emergence of W135 meningococcal serogroup in Chile during 2012
    Valenzuela, M. Teresa
    Moreno, Gabriela
    Vaquerao, Alejandra
    Seoane, Mabel
    Hormazabal, J. Carlos
    Bertoglia, M. Paz
    Gallegos, Doris
    Sotomayor, Viviana
    Diaz, Jorge
    REVISTA MEDICA DE CHILE, 2013, 141 (08) : 959 - 967
  • [42] Primary meningococcal pericarditis by meningococcus serogroup C
    Gutiérrez, MR
    Almeida, JL
    Cerdeña, IL
    Ojeda, FB
    Rodríguez, AD
    Trujillo, DD
    REVISTA ESPANOLA DE CARDIOLOGIA, 2000, 53 (11): : 1541 - 1544
  • [43] Meningococcal disease due to serogroup Y in Scotland, 1992-1999
    Clarke, SC
    Reid, J
    Thom, L
    Denham, BC
    Edwards, GFS
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2001, 58 (01) : 17 - 19
  • [44] Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000
    Djibo, S
    Nicolas, P
    Alonso, JM
    Djibo, A
    Couret, D
    Riou, JY
    Chippaux, JP
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2003, 8 (12) : 1118 - 1123
  • [45] Serogroup B meningococcal disease in persons previously vaccinated with a serogroup B meningococcal vaccine - United States, 2014-2019
    Reese, Heather E.
    McNamara, Lucy A.
    Vianzon, Vianca
    Blain, Amy
    Topaz, Nadav
    Many, Patricia
    Barbeau, Bree
    Albertson, Justin P.
    Lam, Esther
    DeBolt, Charla
    Zaremski, Elizabeth F.
    Hannagan, Susan E.
    Evans, Derek J.
    Hariri, Susan
    Wang, Xin
    Granoff, Dan M.
    Mbaeyi, Sarah
    VACCINE, 2021, 39 (52) : 7655 - 7660
  • [46] Mathematical modeling and analysis of meningococcal meningitis transmission dynamics
    Musa, Salihu Sabiu
    Zhao, Shi
    Hussaini, Nafiu
    Habib, Abdulrazaq Garba
    He, Daihai
    INTERNATIONAL JOURNAL OF BIOMATHEMATICS, 2020, 13 (01)
  • [47] Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence
    Stoof, Susanne P.
    van Ravenhorst, Mariette B.
    van Rooijen, Debbie M.
    de Voer, Richarda M.
    van der Klis, Fiona R. M.
    Boland, Greet J.
    Sanders, Elisabeth A. M.
    Berbers, Guy A. M.
    Teunis, Peter F.
    CLINICAL AND VACCINE IMMUNOLOGY, 2017, 24 (02)
  • [48] Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)
    Bettinger, Julie A.
    Scheifele, David W.
    Halperin, Scott A.
    Vaudry, Wendy
    Findlow, Jamie
    Borrow, Ray
    Medini, Duccio
    Tsang, Raymond
    VACCINE, 2013, 32 (01) : 124 - 130
  • [49] Cutaneous leishmaniasis in Peru using a vector-host model: Backward bifurcation and sensitivity analysis
    Barradas, Ignacio
    Caja Rivera, Rocio Marilyn
    MATHEMATICAL METHODS IN THE APPLIED SCIENCES, 2018, 41 (05) : 1908 - 1924
  • [50] Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial
    van Ravenhorst, Mariette B.
    van der Klis, Fiona R. M.
    van Rooijen, Debbie M.
    Knol, Mirjam J.
    Stoof, Susanne P.
    Sanders, Elisabeth A. M.
    Berbers, Guy A. M.
    VACCINE, 2017, 35 (36) : 4745 - 4752